Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 3 Sponsors

First - Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising — · 1.2K words Open full page ↗

SENATE BILL 987

Q3, J1 6lr3577

By: Senator Lewis Young

Introduced and read first time: February 15, 2026

Assigned to: Rules

A BILL ENTITLED

1 AN ACT concerning

2 Corporate Income Tax – Addition Modification – Direct–to–Consumer

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.

Create a free account Sign in

PASSAGE PROBABILITY

2.2% Unlikely

Why this number

Stage base In Committee — base rate 29%, measured from MD's completed sessions
Momentum -5 27/100 from the pace of recorded action
Time since last action -22 221 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.